
2025 MaTOS Breast | Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Paula Pohlmann, MD, PhD
Date of Release
May 14th, 2025